Used in biomedical research to detect and quantify advanced glycation end products (AGEs) specifically in human glomerular tissue. Helps in studying the role of AGE accumulation in kidney diseases, particularly diabetic nephropathy. Enables researchers to assess glycosylation levels associated with oxidative stress and long-term complications of diabetes. Commonly applied in clinical labs and research settings to evaluate tissue damage mechanisms and potential therapeutic interventions targeting AGE pathways.